These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3518720)
41. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate. Moore EC; Friedman J; Valdivieso M; Plunkett W; Marti JR; Russ J; Loo TL Biochem Pharmacol; 1982 Oct; 31(20):3317-21. PubMed ID: 7150358 [TBL] [Abstract][Full Text] [Related]
42. Propagation of conformational changes in Ni(II)-substituted aspartate transcarbamoylase: effect of active-site ligands on the regulatory chains. Johnson RS; Schachman HK Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1995-9. PubMed ID: 6990418 [TBL] [Abstract][Full Text] [Related]
43. Effects of the T-->R transition on the electrostatic properties of E. coli aspartate transcarbamylase. Hariharan M; Allewell NM Proteins; 1998 Aug; 32(2):200-10. PubMed ID: 9714159 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors. Coudray L; Pennebaker AF; Montchamp JL Bioorg Med Chem; 2009 Nov; 17(22):7680-9. PubMed ID: 19828320 [TBL] [Abstract][Full Text] [Related]
45. Comparison of active mutants and wild-type aspartate transcarbamoylase of Escherichia coli. Vickers LP; Compton JG; Wall KA; Flatgaard JE; Schachman HK J Biol Chem; 1984 Sep; 259(17):11027-35. PubMed ID: 6381492 [TBL] [Abstract][Full Text] [Related]
46. Substrate specificity of aspartate transcarbamylase. Interaction of the enzyme with analogs of aspartate and succinate. Foote J; Lauritzen AM; Lipscomb WN J Biol Chem; 1985 Aug; 260(17):9624-9. PubMed ID: 3894357 [TBL] [Abstract][Full Text] [Related]
47. Effects of N-(phosphonacetyl)-L-aspartate on murine tumors and normal tissues in vivo and in vitro and the relationship of sensitivity to rate of proliferation and level of aspartate transcarbamylase. Johnson RK; Swyryd EA; Stark GR Cancer Res; 1978 Feb; 38(2):371-8. PubMed ID: 620408 [No Abstract] [Full Text] [Related]
48. Quaternary structural changes in aspartate carbamoyltransferase of Escherichia coli at pH 8.3 and pH 5.8. Altman RB; Ladner JE; Lipscomb WN Biochem Biophys Res Commun; 1982 Sep; 108(2):592-5. PubMed ID: 6756403 [No Abstract] [Full Text] [Related]
49. Phosphorus-containing inhibitors of aspartate transcarbamoylase from Escherichia coli. Laing NM; Chan WW; Hutchinson DW; Oberg B FEBS Lett; 1990 Jan; 260(2):206-8. PubMed ID: 2153584 [TBL] [Abstract][Full Text] [Related]
50. 19F nuclear magnetic resonance studies of fluorotyrosine-labeled aspartate transcarbamoylase. Properties of the enzyme and its catalytic and regulatory subunits. Wacks DB; Schachman HK J Biol Chem; 1985 Sep; 260(21):11651-8. PubMed ID: 4044574 [TBL] [Abstract][Full Text] [Related]
51. A facile enzymatic technique for the estimation of nanomolar concentrations of N-phosphonacetyl-L-aspartic acid in plasma. Kensler TW; Jayaram HN; Cooney DA J Biochem Biophys Methods; 1980; 2(1):29-35. PubMed ID: 6999068 [TBL] [Abstract][Full Text] [Related]
52. Effects of replacement of active site residue glutamine 231 on activity and allosteric properties of aspartate transcarbamoylase. Peterson CB; Burman DL; Schachman HK Biochemistry; 1992 Sep; 31(36):8508-15. PubMed ID: 1390636 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA). Jayaram HN; Cooney DA; Vistica DT; Kariya S; Johnson RK Cancer Treat Rep; 1979 Aug; 63(8):1291-302. PubMed ID: 476706 [TBL] [Abstract][Full Text] [Related]
55. Glu-50 in the catalytic chain of Escherichia coli aspartate transcarbamoylase plays a crucial role in the stability of the R quaternary structure. Tauc P; Keiser RT; Kantrowitz ER; Vachette P Protein Sci; 1994 Nov; 3(11):1998-2004. PubMed ID: 7703847 [TBL] [Abstract][Full Text] [Related]
57. Communication between polypeptide chains in aspartate transcarbamoylase. Conformational changes at the active sites of unliganded chains resulting from ligand binding to other chains. Lahue RS; Schachman HK J Biol Chem; 1986 Mar; 261(7):3079-84. PubMed ID: 3512547 [TBL] [Abstract][Full Text] [Related]
58. Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity. Kensler TW; Erlichman C; Jayaram HN; Tyagi AK; Ardalan B; Cooney DA Cancer Treat Rep; 1980; 64(8-9):967-73. PubMed ID: 7448831 [TBL] [Abstract][Full Text] [Related]
60. The illicit permeation of N-delta-phosphonoacetyl-L-ornithine under the form of a tripeptide. Selective inhibition in vivo of Escherichia coli L-ornithine carbamoyltransferase [proceedings]. Penninckx M; Gigot D Arch Int Physiol Biochim; 1979 Feb; 87(1):198-9. PubMed ID: 92272 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]